Screening for Pompe disease in a Portuguese high risk population

[1]  B. Schlotter-Weigel,et al.  Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness , 2016, Neurology.

[2]  A. Oldfors,et al.  Search for Pompe disease among patients with undetermined myopathies , 2016, Acta neurologica Scandinavica.

[3]  Z. Lukacs,et al.  Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: A Spanish cohort , 2015, Neuromuscular Disorders.

[4]  S. García-Morillo,et al.  Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyperCKemia. , 2015, Molecular genetics and metabolism.

[5]  G. Comi,et al.  LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  S. Kiuru-Enari,et al.  Screening for late-onset Pompe disease in Finland , 2014, Neuromuscular Disorders.

[7]  M. Pasnoor,et al.  Pompe disease: literature review and case series. , 2014, Neurologic clinics.

[8]  J. Vissing,et al.  Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies. , 2013, Molecular genetics and metabolism.

[9]  P. Kishnani,et al.  Timing of diagnosis of patients with pompe disease: Data from the pompe registry , 2013, American journal of medical genetics. Part A.

[10]  G. Comi,et al.  Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia. , 2013, Molecular genetics and metabolism.

[11]  David M. Rapoport,et al.  Pompe disease diagnosis and management guideline , 2006, Genetics in Medicine.